Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins
Sign Up to like & getrecommendations! Published in 2017 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s135084
Abstract: Finasteride (FIN) is a Class II candidate of the Biopharmaceutics Classification System (BCS). The lipophilic cavity of cyclodextrins (CyDs) enables it to construct a non-covalent inclusion complex with different insoluble drugs. Only β-cyclodextrin (β-CyD) and… read more here.
Keywords: cyd; inclusion; bioavailability; cyclodextrin cyd ... See more keywords